13F Filings History of Theleme Partners LLP

Latest 13F report
Q4 2025 - 17 Feb 2026
Value $
$1,536,126,802
Signature - Title
Lucy Elwes - Chief Compliance Officer
Location
London, United Kingdom
Summary
This page shows a list of all the recent 13F filings made by Theleme Partners LLP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Theleme Partners LLP reported 9 stock holdings with total value $1,536,126,802 as of Q4 2025. Top holdings included META, MRNA, FLUT, TRU, and WFC.

Notify me when Theleme Partners LLP files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 9 $1,536,126,802 +$184,498,885 -$183,485,329 +$1,013,556 META, MRNA, FLUT, TRU, WFC 13F-HR 17 Feb 2026, 15:04
Q3 2025 10 $1,564,526,676 +$103,996,625 -$171,926,892 -$67,930,267 META, WFC, MRNA, TRU, UBER 13F-HR 13 Nov 2025, 13:28
Q2 2025 10 $1,645,236,037 +$382,729,938 -$145,012,580 +$237,717,358 MRNA, WFC, META, TRU, FLUT 13F-HR 13 Aug 2025, 17:43
Q1 2025 12 $1,272,358,670 +$130,223,038 -$201,521,153 -$71,298,115 MRNA, AMZN, WFC, TRU, EFX 13F-HR 14 May 2025, 18:08
Q4 2024 11 $1,492,007,448 +$616,596,655 -$597,620,147 +$18,976,508 MRNA, BAC, WFC, AMZN, EFX 13F-HR 13 Feb 2025, 18:15
Q3 2024 10 $1,696,248,923 +$303,348,447 -$316,120,181 -$12,771,734 MRNA, SCHW, TRU, EFX, HRI 13F-HR 14 Nov 2024, 12:52
Q2 2024 8 $2,010,686,079 +$232,447,994 -$120,073,950 +$112,374,044 MRNA, SCHW, WFC, TRU, HRI 13F-HR 13 Aug 2024, 17:45
Q1 2024 7 $1,819,957,942 +$124,028,358 -$348,771,445 -$224,743,087 MRNA, SCHW, WFC, HRI, TRU 13F-HR 14 May 2024, 10:34
Q4 2023 9 $1,896,616,232 +$137,946,920 -$453,283,598 -$315,336,678 MRNA, SCHW, WFC, HRI, TSM 13F-HR 13 Feb 2024, 09:55
Q3 2023 10 $1,991,301,842 +$187,706,252 -$204,797,098 -$17,090,846 MRNA, SCHW, WFC, QCOM, URI 13F-HR 13 Nov 2023, 18:01
Q2 2023 9 $2,209,371,965 +$279,899,892 -$250,021,754 +$29,878,138 MRNA, WFC, SCHW, URI, AA 13F-HR 11 Aug 2023, 18:21
Q1 2023 11 $2,325,443,336 +$338,476,562 -$386,305,629 -$47,829,067 MRNA, WFC, SCHW, AA, QCOM 13F-HR 12 May 2023, 17:35
Q4 2022 10 $2,600,988,683 +$236,823,935 -$198,420,332 +$38,403,603 MRNA, WFC, SCHW, AA, URI 13F-HR 10 Feb 2023, 16:14
Q3 2022 10 $2,050,501,000 +$58,788,415 -$252,976,049 -$194,187,634 MRNA, WFC, SCHW, META, AA 13F-HR 14 Nov 2022, 12:12
Q2 2022 12 $2,495,526,000 +$167,477,401 -$95,745,574 +$71,731,827 MRNA, WFC, LRCX, META, AA 13F-HR 12 Aug 2022, 11:14
Q1 2022 11 $3,130,870,000 +$622,822,306 -$298,452,106 +$324,370,200 MRNA, WFC, AA, LRCX, META 13F-HR 13 May 2022, 13:37
Q4 2021 9 $3,246,011,000 +$704,467,768 -$573,938,919 +$130,528,849 MRNA, WFC, AA, META, MU Restatement 26 May 2022, 12:11
Q3 2021 7 $3,503,184,000 +$367,657,327 -$1,148,012,421 -$780,355,094 MRNA, WFC, META, AA, TMUS Restatement 26 May 2022, 12:04
Q2 2021 9 $3,424,992,000 +$203,265,228 -$620,872,373 -$417,607,145 MRNA, WFC, TMUS, ADI, MU 13F-HR 13 Aug 2021, 14:26
Q1 2021 12 $2,988,347,000 +$437,785,285 -$730,470,588 -$292,685,303 MRNA, WFC, TMUS, AZO, MU 13F-HR 13 May 2021, 12:36
Q4 2020 15 $2,870,610,000 +$1,040,330,445 -$730,627,009 +$309,703,436 WFC, MRNA, TMUS, CARR, MU 13F-HR 12 Feb 2021, 16:04
Q3 2020 15 $2,039,753,000 +$275,001,244 -$347,225,487 -$72,224,243 MRNA, WFC, URI, VMC, BKNG 13F-HR 13 Nov 2020, 14:48
Q2 2020 14 $1,970,815,000 +$542,271,447 -$238,295,274 +$303,976,173 MRNA, WFC, URI, VMC, BKNG 13F-HR 13 Aug 2020, 19:34
Q1 2020 13 $1,223,429,000 +$449,057,367 -$577,337,012 -$128,279,645 WFC, MRNA, URI, BA, MU 13F-HR 14 May 2020, 17:39
Q4 2019 7 $1,775,359,000 +$78,600,367 -$406,057,367 -$327,457,000 WFC, BAC, URI, AXP, MRNA 13F-HR 13 Feb 2020, 10:03
Q3 2019 10 $1,888,934,000 +$238,619,292 -$113,513,971 +$125,105,321 WFC, BAC, URI, SCHW, AXP 13F-HR 13 Nov 2019, 14:54
Q2 2019 9 $1,675,713,000 +$356,949,046 -$353,640,151 +$3,308,895 WFC, BAC, SCHW, URI, KLAC 13F-HR 13 Aug 2019, 20:38
Q1 2019 8 $1,674,905,000 +$271,421,788 -$355,423,708 -$84,001,920 BAC, WFC, SCHW, UTX, AXP 13F-HR 15 May 2019, 14:19
Q4 2018 9 $1,636,659,000 +$153,573,743 -$59,827,848 +$93,745,895 WFC, SCHW, BAC, UTX, SPGI 13F-HR 13 Feb 2019, 18:12
Q3 2018 7 $1,825,600,000 +$68,147,915 -$159,126,523 -$90,978,608 WFC, SCHW, BAC, UTX, SPGI 13F-HR 13 Nov 2018, 16:29
Q2 2018 8 $1,930,689,000 +$243,549,282 -$272,368,505 -$28,819,223 SCHW, WFC, BAC, BACWSA, UTX 13F-HR 13 Aug 2018, 15:52
Q1 2018 7 $1,990,838,000 +$158,276,087 -$88,364,693 +$69,911,394 SCHW, WFC, BAC, BACWSA, SPGI 13F-HR 14 May 2018, 13:45
Q4 2017 6 $1,955,303,000 +$129,006,156 -$266,980,256 -$137,974,100 SCHW, WFC, BAC, BACWSA, SPGI 13F-HR 14 Feb 2018, 10:32
Q3 2017 7 $1,808,936,000 +$77,076,000 -$89,881,539 -$12,805,539 BAC, SCHW, WFC, BACWSA, SPGI 13F-HR 13 Nov 2017, 10:50
Q2 2017 6 $1,770,118,000 +$13,343,010 -$184,298,938 -$170,955,928 SCHW, BAC, WFC, BACWSA, SPGI 13F-HR 11 Aug 2017, 13:24
Q1 2017 7 $1,873,469,000 +$104,122,642 -$114,640,143 -$10,517,501 SCHW, BAC, WFC, SPGI, BACWSA 13F-HR 12 May 2017, 12:59
Q4 2016 7 $1,772,192,000 +$79,434,613 -$54,760,217 +$24,674,396 SCHW, BAC, WFC, SPGI, BACWSA 13F-HR 13 Feb 2017, 10:22
Q3 2016 6 $1,387,656,000 +$162,495,167 -$244,719,772 -$82,224,605 SCHW, BAC, WFC, SPGI, CHTR 13F-HR 14 Nov 2016, 14:23
Q2 2016 7 $1,330,753,000 +$202,912,619 -$344,231,297 -$141,318,678 WFC, SCHW, BAC, VMC, SPGI 13F-HR 12 Aug 2016, 10:06
Q1 2016 8 $1,490,195,000 +$216,197,771 -$105,647,880 +$110,549,891 WFC, SCHW, BAC, VMC, MHFI 13F-HR 13 May 2016, 10:17
Q4 2015 8 $1,519,592,000 +$57,170,817 -$66,146,998 -$8,976,181 WFC, SCHW, BAC, VMC, MHFI 13F-HR 12 Feb 2016, 11:02
Q3 2015 8 $1,409,846,000 +$105,625,954 -$126,804,980 -$21,179,026 WFC, SCHW, BAC, VMC, MHFI 13F-HR 13 Nov 2015, 13:23
Q2 2015 9 $1,565,866,000 +$179,106,546 -$173,494,047 +$5,612,499 WFC, SCHW, BAC, MHFI, VMC 13F-HR 13 Aug 2015, 11:31
Q1 2015 9 $1,490,320,000 +$165,050,028 -$332,275,719 -$167,225,691 WFC, SCHW, BAC, MHFI, MSFT 13F-HR 14 May 2015, 09:56
Q4 2014 8 $1,670,900,000 +$221,242,605 -$130,666,259 +$90,576,346 WFC, SCHW, BAC, MHK, MHFI 13F-HR 13 Feb 2015, 14:56
Q3 2014 8 $1,507,732,000 +$90,975,416 -$127,954,072 -$36,978,656 WFC, SCHW, BAC, MHFI, MHK 13F-HR 13 Nov 2014, 10:34
Q2 2014 10 $1,504,632,000 +$141,754,084 -$207,475,657 -$65,721,573 WFC, SCHW, BAC, MHFI, LOW 13F-HR 13 Aug 2014, 13:18
Q1 2014 12 $1,533,246,000 +$142,978,800 -$349,268,350 -$206,289,550 WFC, SCHW, BAC, MHFI, LOW 13F-HR 14 May 2014, 10:13
Q4 2013 14 $1,687,140,000 $0 $0 $0 WFC, SCHW, AXP, BAC, MHFI 13F-HR 13 Feb 2014, 09:21